Drug Profile
Imiglucerase biosimilar - Harvest Moon Pharmaceuticals
Alternative Names: Recombinant glucocerebrosidase - Harvest Moon PharmaceuticalsLatest Information Update: 19 Feb 2016
Price :
$50
*
At a glance
- Originator Harvest Moon Pharmaceuticals
- Class Glucosidases
- Mechanism of Action Glucosylceramidase replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Gaucher's disease
Most Recent Events
- 19 Feb 2016 No recent reports on development identified - Phase-III for Gaucher's disease in Brazil (Parenteral)
- 22 Aug 2013 Phase-III clinical trials in Gaucher's disease in Brazil (Parenteral)